Thermo Fisher Scientific Inc. (NYSE:TMO) and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing.  Innoforce is a Hangzhou, China-based contract development and manufacturing company. The two companies expect to complete the facility in 2022.   The site will become part of Thermo Fisher’s…